Original Research
Accepted on 21 Feb 2025
TcSR62, an RNA-binding protein, as a new potential target for anti-trypanocidal agents
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 21 Feb 2025
in Antimicrobials, Resistance and Chemotherapy
Review
Accepted on 21 Feb 2025
in Antimicrobials, Resistance and Chemotherapy
Opinion
Published on 21 Feb 2025
in Antimicrobials, Resistance and Chemotherapy
Review
Published on 21 Feb 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 19 Feb 2025
in Antimicrobials, Resistance and Chemotherapy
Systematic Review
Published on 19 Feb 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Published on 18 Feb 2025
in Antimicrobials, Resistance and Chemotherapy
Editorial
Published on 18 Feb 2025
in Antimicrobials, Resistance and Chemotherapy
Review
Accepted on 17 Feb 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 17 Feb 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 17 Feb 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Published on 17 Feb 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Published on 14 Feb 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 13 Feb 2025
in Antimicrobials, Resistance and Chemotherapy
Review
Published on 13 Feb 2025
in Antimicrobials, Resistance and Chemotherapy
Review
Published on 13 Feb 2025
in Antimicrobials, Resistance and Chemotherapy